Therefore, the goal of this study is to evaluate the effect of APOE ε4 status on amyloid deposition, neurodegeneration, and cognition in patients diagnosed with E-MCI, the earliest clinically-defined prodromal stage of AD. Here, APOE is linked to Alzheimer disease.